Bristol-Myers Squibb's total assets for Q1 2026 were $86.48B, a decrease of -3.96% from the previous quarter. BMY total liabilities were $66.37B for the fiscal quarter, a -7.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.